AACC
The program uses an informatics system that converts genotype results to "traffic lights" telling clinicians whether a drug is acceptable for a certain patient.
The researchers believe that combining liquid and tissue biopsy can improve diagnostic and therapeutic options for cancer patients with acquired drug resistance mutations.
AACC Drug Testing Guidelines Take Steps Toward Reducing Excessive Drug Panel Testing
The guidelines are the first to attempt to specify which drugs are appropriate to test for routinely, guideline authors say.
Theranos Offers First Glimpse of Technologies, Assay Data to Critical Lab Community
At the American Association for Clinical Chemistry meeting, Theranos CEO Elizabeth Holmes said her company is working on third-party review and publications of the firm's technologies and tests.
At AACC, Clinical Labs Air Concerns Regarding FDA's Draft LDT Guidance
The draft guidance has created anxiety among clinical laboratory managers, who worry about how FDA will define LDTs, among other concerns.